Navigation Links
MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference
Date:2/2/2009

VALENCIA, Calif., Feb. 2 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference on Monday, February 9, 2009 at 2:15 PM (EST) at the Hilton Waldorf Astoria in New York City. In addition to this presentation, the Company will host a breakfast meeting for invited investors and analysts at 7:30 AM (EST) on February 10th.

Interested parties can access links to live webcasts of both presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com. Replays of the presentations will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its pipeline includes AFRESA, which has completed Phase 3 clinical trials, and MKC253, which is currently in Phase 1 clinical trials. Both of these investigational products are being evaluated for their safety and efficacy in the treatment of diabetes. MannKind maintains a website at https://www.mannkindcorp.com to which MannKind regularly posts copies of its press release as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to email alerts that are sent automatically when MannKind issues press releases, files its reports with the SEC or posts certain other information to the website.


'/>"/>
SOURCE MannKind Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
2. MannKind to Present at the Piper Jaffray 20th Annual Health Care Conference
3. MannKind to Present at the Rodman & Renshaw Annual Global Investment Conference
4. MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008
5. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
6. MannKind to Present at the UBS Global Life Sciences Conference
7. MannKind Corporation Reports Second Quarter Financial Results
8. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
9. MannKind to Present at Upcoming Conferences
10. MannKind Corporation Reports First Quarter Financial Results
11. MannKind to Present at the Morgan Stanley Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical ... and voluntary market withdrawal of one lot of the ... taking this action because some Daytrana patches do not ... release liner removal specification, and as a result, patients ...
(Date:12/3/2009)... Life Sciences, Inc. (Nasdaq: CALP ), a leading ... life sciences research, today introduced Living Image 4.0 software ... drives the more than 800 Caliper IVIS systems currently ... spectral unmixing tools to enhance fluorescent sensitivity and automated ...
(Date:12/2/2009)... MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging ... the planet. Through the efforts of True Green Energy Group ... who has been in the recycling business for over 25 ... of everyone and is setting the stage for spectacular earnings ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Drug Discovery Technologies - A Global ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery ... of every pharmaceutical company,s business strategy. There ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... ... Contract Manufacturing of DaySpring Core ... Products ... 1 Carrington,Laboratories, Inc. (Pink Sheets: CARN) ( http://www.CarringtonLabs.com ),today announced it has formalized ...
... Corporation, the,leader in room temperature biosample management, together ... presenting data showing stabilization,of RNA on GenVault,s Reversible ... the 18th International Symposium on Human Identification in,Hollywood, ... is a novel technology utilizing ceramic,nanoparticles and a ...
... BioSciences, Inc.,co-founded by Dr. Leonard Bjeldanes, Professor and ... UC Berkeley and Dr. Gary Firestone,Director of the ... UC,Berkeley, announces the launch of ActivaMune -- an ... http://www.ActivaMune.com/ ). ActivaMune is based on a ...
Other Biology Technology:Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market 2Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market 3GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA 2Advanced Immune Support Formula Licensed From UC Berkeley Launched 2
(Date:12/4/2009)... organs relevant for coronary artery disease (CAD), scientists at ... module of genes that is important for the recruitment ... findings, which are to be published in the open-access ... migration of white blood cells in the development of ...
(Date:12/4/2009)... in German . , A new study ... help to understand the positive effect of dietary restriction on ... mice) have shown that dietary restriction increases longevity, but with ... female fruit fly reproduces less frequently with a reduced litter ...
(Date:12/3/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... biometric identification solutions, announced that a majority of ... today approved the sale of the company,s Law ... the shares voted, 98.6% were cast in favor ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Walk the Weight Off with Shape Up Tips from Leading National Walking Expert Leslie Sansone and Nutrisystem 55892 1Walk the Weight Off with Shape Up Tips from Leading National Walking Expert Leslie Sansone and Nutrisystem 55892 2Walk the Weight Off with Shape Up Tips from Leading National Walking Expert Leslie Sansone and Nutrisystem 55892 3Walk the Weight Off with Shape Up Tips from Leading National Walking Expert Leslie Sansone and Nutrisystem 55892 4Walk the Weight Off with Shape Up Tips from Leading National Walking Expert Leslie Sansone and Nutrisystem 55892 5Walk the Weight Off with Shape Up Tips from Leading National Walking Expert Leslie Sansone and Nutrisystem 55892 6Physicians Interactive Names Sanjay Pingle President 55887 1Physicians Interactive Names Sanjay Pingle President 55887 2Physicians Interactive Names Sanjay Pingle President 55887 3Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 1Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 2Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 3Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 4
... of Delaware has received $400,000 from the National Oceanic ... ocean observing system for the Mid-Atlantic region, spanning the ... and out to the continental shelf. Nearly 25 percent ... , The initiative is part of the national Integrated ...
... depleted. Traditional energy sources, like oil, have become hostages ... may depend on renewable energy new technology that ... University has just taken a big step toward making ... conference on renewable energy last month, Tel Aviv University ...
... on a compound found in cocoa beans slowed growth ... and should be tested further for cancer chemoprevention or ... , "We have all heard that eating chocolate is ... that might be true," says the study,s lead author ...
Other Biology News:UD nets NOAA funding for Mid-Atlantic ocean observing 2TAU announces new 'supercenter' for renewable energy 2TAU announces new 'supercenter' for renewable energy 3Synthetic cocoa chemical slows growth of tumors in human cell lines 2
...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... CrysScreen is a software package that ... interface for custom buffer creation, set-up ... in crystallization trials. The software helps ... in automated protein crystallography: ...
BD Falcon insert HTS 96 well, square A-bottom with lid. PET membrane, sterile. (5/ca) Packaging: 5 / pack, 5 / case ...
Biology Products: